Kimiya is developing next-generation microfluidic devices and systems by combining molecular design, organic synthesis, nanotechnology, microelectronics, data analytics and software design

One of our target applications is portable molecular diagnostics to test for disease anywhere, anytime, with the precision of nucleic acid analysis.

Molecular diagnostic techniques, along with leading-edge technology in microfluidics, will deliver rapidly deployable, portable diagnostic devices for the diagnosis of bacterial, viral and fungal diseases.

Healthcare systems worldwide are under increasing pressure to rapidly and cost-effectively diagnose diseases. Early diagnosis that is both precise and sophisticated will deliver better patient outcomes, reduced healthcare costs for patients and providers, inform targeted antimicrobial therapies and deliver rapid analytical data when diseases appear.